Buccal metastasis in a case of carcinoma breast: A rare case report with review of literature  by Jain, Sunny et al.
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INTRODUCTION:  Metastatic  lesions  to oral  cavity  from  distant  tumours  account  for  1%  of all  oral  cavity
malignancies.  Oral cavity  is a  rare  site  of  metastasis  from  the breast.  We describe  case  report  of breast
cancer  patient  with  metastasis  to  buccal  mucosa.
PRESENTATION  OF  CASE: We report  a case  of pre-menopausal  woman  with  left  side  inﬁltrating  ductal
carcinoma  breast  –  T4aN1M0.  She  received  three  cycles  of neo-adjuvant  chemotherapy  followed  by
modiﬁed  radical  mastectomy  (MRM)  and  three  cycles  of adjuvant  chemotherapy  and loco-regional  EBRT.
She presented  with  a lump  in region  of  MRM  scar  and  a  painful  swelling  in the  right cheek,  one  year
afterwards.  Core  needle  biopsy  from  scar  site  revealed  inﬁltrating  ductal  carcinoma.  CECT  revealed  a
heterogeneous  lesion  (1.1  cm  × 1.7  cm)  in  right  masticator  space,  which  on  biopsy  revealed  metastatic
deposit  consistent  with  inﬁltrating  ductal  carcinoma.
DISCUSSION:  Metastatic  lesions  to  oral  cavity  from  distant  tumours  are uncommon.  They  mainly  involve
bony structures.  Primary  metastases  to soft tissues  are  rare  and  accounts  for 0.1%  of oral  malignancies.
In  our  case,  patient  presented  with  scar  recurrence  and  distant  metastasis  at an  unusual  site.  Had  it not
been  for  scar  recurrence,  patient  might  not  have  presented  to the  OPD  with  oral  swelling.  A high degree
of  clinical  suspicion  and  previous  history  of  breast  cancer  led to  detection  of metastatic  deposit.
CONCLUSION:  Diagnosis  of a metastatic  lesion  in  buccal  mucosa  is  challenging  and requires  a high  degree
of  clinical  suspicion.
gical© 2013 Sur
. Introduction
Metastatic lesions to the oral cavity from distant tumours
re uncommon, accounting for only 1% of all oral cavity malig-
ancies. They mainly involve the bony structures (particularly
he mandible), whereas primary metastases to soft tissues are
xtremely rare (only 0.1% of oral malignancies).1 The most com-
on  sites of metastasis are the tongue and gingiva followed by the
ips, with occasional case reports of metastasis to the palatal or buc-
al mucosa.2 We  describe a case report of a patient of breast cancer
ith metastasis to the buccal mucosa.
. Case presentation
We report a case of 30-year-old pre-menopausal woman  who
resented with a left sided breast lump, which was diagnosed as
 case of inﬁltrating ductal carcinoma (triple negative) on core
eedle biopsy (T4aN1M0). Patient also had mobile Axillary lymph
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nodes in the ipsilateral axilla. Her metastatic work-up at the time
of diagnosis was normal. Her computed tomography scan at that
time reported a 6.1 cm × 5.7 cm × 7.2 cm heterogeneously enhanc-
ing mass lesion in left breast upper outer quadrant; involving
pectoralis major and pectoralis minor. Left axilla shows heteroge-
neously enhancing node of 1.8 cm × 2 cm,  fatty hila is lost. Clinically
the mass was  ﬁxed to the chest wall. The patient was  started
on neo-adjuvant chemotherapy (NACT) with cyclophosphamide,
doxorubicin, 5-ﬂuorouracil (CAF) regimen and patient underwent
modiﬁed radical mastectomy (MRM)  after three cycles of NACT.
Histological examination of the specimen revealed inﬁltrating duc-
tal carcinoma (Fig. 1) with 4 out of 12 Axillary lymph nodes positive
(Fig. 2). Patient then received three cycles of adjuvant chemother-
apy and was  being planned for adjuvant radiotherapy. Patient was
treated on outpatient basis and was  given external beam radiothe-
rapy using Co-60 teletherapy machine. Patient was laid supine with
arm abducted at 90◦ and head turned to opposite side. Breast tilt
board with arm rest was used to stabilize the position. Radiotherapy
was given using bilateral tangential ﬁelds along with supraclavi-
cular and Axillary lymph nodal irradiation. Entire chest wall was
Open access under CC BY-NC-ND license.included in the ﬁeld with upper margin placed at head of the clavi-
cle and lower margin was 2 cm inferior to the infra mammary fold.
Medial border was 1 cm over the midline and lateral-posterior bor-
der in the mid  Axillary line. Patient received a total tumour dose of
Y-NC-ND license.
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Fig. 1. Microscopic picture depicting inﬁltrating ductal carcinoma breast with BR
score of 8. Inset (a) shows focal DCIS was observed in this case with comedo necrosis.
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Fig. 3. A 1.1 cm × 1.7 cm peripherally enhancing lesion is noted in right masticator
space anterior to masseter muscle. The central part does not enhance suggestive
of  necrosis. Mild stranding is noted in surrounding fat. Posteriorly the lesion abuts
masseter muscle. In k/c/o Ca breast ﬁndings are suggestive of deposit in masticator
space.
uncommon, accounting for only 1% of all oral malignancies. TheyFig. 2. Microscopic picture showing lymph node inﬁltration by the tumour.
0 Gy/25#/5 weeks at 2 Gy/#/day for 5 days a week. For supracla-
icular lymph node irradiation lower border was  matched to the
pper border of the tangential ﬁeld and medial border was 1 cm
cross the midline, extending upwards following medial border
f sternocleidomastoid to thyrocricoid groove. Lateral border was
xtended laterally to cover 2/3 of the humoral head to treat full
xilla and a dose of 50 Gy/25#/5 weeks was given. Additional pos-
erior Axillary boost was given after 17# of EBRT. Following which
atient was lost to follow-up.
She presented one year later to the surgical clinic with com-
laints of a lump in the region of the MRM  scar and another
ard, painful swelling in the right cheek, which was progressively
ncreasing in size for the last 2 months. Fine needle aspiration cytol-
gy (FNAC) and core needle biopsy from the scar site lump revealed
nﬁltrating ductal carcinoma.
A contrast enhanced computed tomography (CT) scan of the
ead and neck revealed a round heterogeneous lesion with rim
nhancement measuring 1.1 cm × 1.7 cm in the right masticator
pace (Fig. 3). FNAC (ﬁne needle aspiration cytology) from the
heek swelling, revealed a metastatic deposit of malignant cells. A
iopsy from the swelling revealed a metastatic deposit consistent
ith inﬁltrating ductal carcinoma (Fig. 4). Immunohistochemistry
evealed a triple negative carcinoma. A bone scan and abdominal
ltrasound were normal.Fig. 4. A trucut biopsy the nodule in masticator space showing malignant cell cluster
with a lymphoplasmacytic inﬂammatory response. Inset (b) shows a high power
ﬁeld  of the same nodule.
Patient was explained about the surgical procedure, associ-
ated complications and prognosis after the procedure. However,
the patient did not consent for surgery. Following which she was
taken up for palliative treatment with docetaxel and cisplatin based
chemotherapy regimen.
3. Discussion
The diagnosis of metastasis to the oral cavity is a challenge
to the clinician because of the lack of pathognomonic signs and
symptoms. A high index of clinical suspicion is necessary when
evaluating patients with a history of no head and neck carcinoma.
Metastatic lesions to the oral cavity from distant tumours aremainly involve the bony structures (particularly the mandible),
whereas primary metastases to soft tissues are extraordinarily rare
(only 0.1% of oral malignancies). The most common sites of soft
 –  O
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issue involvement are the gingiva, tongue, lips and the buccal and
alatal mucosa. The primary tumours are mainly lung, breast, kid-
ey and colon.1
Detection of oral lesions has great importance because they
ight be diagnosed ﬁrst by the patient’s dentist or the max-
llofacial surgeon. The clinical presentation of metastatic lesions
s different in various oral sites.3 Patients often have vague or
nnocuous symptoms that can mimic  dental infections, and some-
imes the disease might be totally asymptomatic.4,5 In a review
f 114 cases of metastatic jaw tumours, D’Silva et al.4 found
hat the most common jaw symptom was pain. Other signs and
ymptoms included swelling, presence of intraoral mass, loose
r extruded teeth, cortical expansion, regional lymphadenopathy,
um irritation, ulceration, exophytic growth, halitosis, numbness or
aresthesia of the lower lip, and trismus.5 Special attention should
e given to patients with numb-chin syndrome or mental nerve
europathy, a symptom that should always raise the suspicion of a
etastatic disease in the mandible.6
In most cases of oral metastasis, the distant primary tumour has
lready been diagnosed and often treated. Sometimes, however, the
iscovery of an oral metastasis leads to the detection of an occult
rimary malignancy elsewhere in the body.3,7 In about one third of
atients the oral lesion is diagnosed before the primary tumour.7,8
In our case, the patient presented simultaneously with scar
ecurrence and distant metastasis at an unusual site. Had it not
een for the scar recurrence, the patient might not have presented
o the out patient department (OPD) with the oral swelling. A high
egree of clinical suspicion and previous history of breast cancer
ed to the detection of the metastatic deposit.
The clinical presentation and radiographic ﬁndings of a
etastatic lesion can be deceiving, leading to a misdiagnosis of
 benign process; therefore in such cases, especially in patients
ith a history of malignant disease, biopsy is mandatory for exact
istopathological co relation.3 Taking a thorough medical history
long with a panel of immunohistochemical stains may  be helpful
n making the diagnosis.4 In our case, after the history of breast
ancer was established, a biopsy was performed. In addition, the
athologic slides of the breast tumour were requested and com-
ared with the buccal lesion, which conﬁrmed the ﬁnal diagnosis.
Most of the patients with a metastases in the oral cavity also
evelop metastases at other sites, often leaving no other option
han palliation.7–10 However, Anderson Cancer Center has reported
 15-year disease-free survival rate of 24% in 134 patients with soli-
ary loco regional recurrences or metastases treated with surgical
esection, systemic therapy, and in selected cases, radiotherapy.11
ieto et al. reported the outcome of 60 patients with minimal
etastatic disease treated with surgery and/or radiation ther-
py and high-dose chemotherapy. Included in this group were 17
atients with distant metastases at the time of breast cancer diag-
osis. After a median follow-up of 62 months, 51.6% of the entire
atient group (95% CI, 39–64%) remained alive and free of dis-
ase. In the patients with metastatic disease at presentation, 46% of
hose with distant metastases and three of four with supraclavicu-
ar metastases were alive and free of disease.12 Herein this case the
atient did not consent for the surgery. Local treatment gives relief
n pain and may  also prevent loss of function.7 In general, survival of
atients with advanced disease including metastases is poor, with
aximum number of patients dying within a year of detection of
he bony metastasis.4
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4. Conclusion
Because of its rarity, the diagnosis of a metastatic lesion in
the masticator space (buccal mucosa) is challenging. This case
emphasized the importance of a complete and careful work-up,
with particular attention to detailed medical history as well as
careful clinical and radiographic inspection for unusual signs and
symptoms. Immunohistochemistry correlation of the metastatic
lesion in line with primary site also plays an important role
in ruling out second primary in such cases of rare presenta-
tions.
Conﬂict of interest
None.
Funding
None.
Ethical approval
Informed consent was taken.
Author’s contribution
Besides, writing the full content, Sunny Jain had done data col-
lection with the help of Mohit Kadian and Rohan Khandelwal, and
Sunny Jain had made data analysis teaming with Usha Agarwal and
K.T. Bhowmik.
References
1. Nandakumar A, Gupta PC, Gangadharan P, Visweswara RN, Parkin DM.  Geo-
graphic pathology revisited: development of an atlas of cancer in India.
International Journal of Cancer 2005;116:740–54.
2.  Solomon MP,  Gormley M,  Jarrett W,  Rosen Y. Metastatic lesions to the oral soft
tissues. Journal of Oral Surgery 1975;33:53–6.
3. Hirshberg A, Shnaiderman-Shapiro A, Kaplan I, Berger R. Metastatic tumours
to  the oral cavity – pathogenesis and analysis of 673 cases. Oral Oncology
2008;44:743–52.
4. D’Silva NJ, Summerlin DJ, Cordell KG, Abdelsayed RA, Tomich CE, Hanks CT, et al.
Metastatic tumors in the jaws: a retrospective study of 114 cases. Journal of the
American Dental Association 2006;137:1667–72.
5. Boyczuk EM,  Solomon MP,  Gold BD. Unremitting pain to the mandible secondary
metastatic breast cancer: a case report. Compendium 1991;12.  pp. 104, 106,
108–110.
6.  Ryba F, Rice S, Hutchison IL. Numb chin syndrome: an ominous clinical sign.
British Dental Journal 2010;208:283–5.
7.  van der Waal RI, Buter J, van der Waal I. Oral metastases: report of 24 cases.
British Journal of Oral and Maxillofacial Surgery 2003;41:3–6.
8.  Pruckmayer M,  Glaser C, Marosi C, Leitha T. Mandibular pain as the leading
clinical symptom for metastatic disease: nine cases and review of the literature.
Annals of Oncology 1998;9:559–64.
9.  Ogu¨ tcen-Toller M, Metin M,  Yildiz L. Metastatic breast carcinoma mim-
icking periodontal disease on radiographs. Journal of Clinical Periodontology
2002;29:269–71.
0.  Panossian M,  Gady J, Natarajan E, Eisenberg E. Breast cancer metastatic to the
mandible misdiagnosed as parotitis: report of a case. Journal of Oral and Max-
illofacial Surgery 2009;67:1333–7.
1.  Holmes FA, Buzdar AU, Kau SW.  Combined-modality approach for patients with
isolated recurrences of breast cancer (IV-NED): the MD Anderson experience.
Breast Disease 1994;7:7–20.
2. Nieto Y, Nawaz S, Jones RB, Shpall EJ, Cagnoni PJ, McSweeney PA, et al. Progno-
stic  model for relapse after high-dose chemotherapy with autologous stem-cell
transplantation for stage IV oligometastatic breast cancer. Journal of Clinical
Oncology 2002;20:707–18.
